Regional Analysis
Global Artificial Intelligence (AI) Diagnostics Market: Regional Insights
- Based on geography, the global artificial intelligence (AI) diagnostics market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.
- Among regions, increasing adoption of Artificial Intelligence (AI) in disease identification & diagnostics, and increasing investment in AI healthcare startups are factors expected to drive North America’s AI in diagnostics market. In addition, growing demand for reducing diagnostic costs, improving patient care, and reducing machine downtime are further accelerating usage of AI in diagnostics. According to Health IT Analytics in May 2017, researchers from Case Western Reserve University used a deep learning network, which is a subset of AI, to identify breast cancer in pathology images with 100% accuracy.
- Increasing patient pool, ongoing pandemic, growing acceptance of cloud computing, and rising number of government programs supporting AI are among the key factors expected to drive the market in Asia Pacific. In addition, an increasing number of biopharmaceutical firms are applying AI to modernize the drug discovery process, with more AI applications being found in the field of diagnostics. For instance, in 2017, China’s Tencent introduced an AI-driven diagnostic medical imaging facility, called AI Medical Innovation System (AIMIS). The technology exhibited 90% and 95% accuracy for initial diagnoses of esophageal & lung cancers, respectively.
| Geographies covered: |
- North America: U.S. and Canada
- Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
- Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
- Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
- Middle East: GCC Countries, Israel, and Rest of Middle East
- Africa: South Africa, North Africa, and Central Africa
|
U.S.: 
U.K. : 
India : 
